ES8308324A1 - Un procedimiento para la preparacion de un compuesto. - Google Patents

Un procedimiento para la preparacion de un compuesto.

Info

Publication number
ES8308324A1
ES8308324A1 ES515366A ES515366A ES8308324A1 ES 8308324 A1 ES8308324 A1 ES 8308324A1 ES 515366 A ES515366 A ES 515366A ES 515366 A ES515366 A ES 515366A ES 8308324 A1 ES8308324 A1 ES 8308324A1
Authority
ES
Spain
Prior art keywords
pyridyl
alkoxy
alkyl
hydrogen
imidazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515366A
Other languages
English (en)
Spanish (es)
Other versions
ES515366A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES515366A0 publication Critical patent/ES515366A0/es
Publication of ES8308324A1 publication Critical patent/ES8308324A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES515366A 1981-08-31 1982-08-30 Un procedimiento para la preparacion de un compuesto. Expired ES8308324A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29822481A 1981-08-31 1981-08-31

Publications (2)

Publication Number Publication Date
ES515366A0 ES515366A0 (es) 1983-08-16
ES8308324A1 true ES8308324A1 (es) 1983-08-16

Family

ID=23149579

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515366A Expired ES8308324A1 (es) 1981-08-31 1982-08-30 Un procedimiento para la preparacion de un compuesto.

Country Status (19)

Country Link
EP (1) EP0074229B1 (enExample)
JP (1) JPS5846083A (enExample)
KR (1) KR860000103B1 (enExample)
AR (1) AR230994A1 (enExample)
AT (1) ATE19078T1 (enExample)
AU (1) AU534063B2 (enExample)
CA (1) CA1177485A (enExample)
DE (1) DE3270423D1 (enExample)
DK (1) DK160303C (enExample)
ES (1) ES8308324A1 (enExample)
FI (1) FI78085C (enExample)
GR (1) GR77241B (enExample)
HU (1) HU188328B (enExample)
IE (1) IE53586B1 (enExample)
IL (1) IL66673A (enExample)
PH (1) PH17423A (enExample)
PL (1) PL134315B1 (enExample)
PT (1) PT75481A (enExample)
YU (1) YU42795B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004229392A1 (en) 2003-04-09 2004-10-28 Exelixis, Inc. Tie-2 modulators and methods of use
BRPI1011192A2 (pt) 2009-05-07 2016-03-15 Gruenenthal Gmbh derivados de carboxamida e ureia aromáticas substituídas como ligantes de receptor de vaniloide, composição farmacêutica, uso e processo para preparação dos referidos derivados
EP2431035A1 (en) * 2010-09-16 2012-03-21 Æterna Zentaris GmbH Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
CA3166630A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276297A (en) * 1979-06-18 1981-06-30 Pfizer Inc. Pyridylaminotriazole therapeutic agents

Also Published As

Publication number Publication date
JPS5846083A (ja) 1983-03-17
IL66673A (en) 1986-04-29
ES515366A0 (es) 1983-08-16
IL66673A0 (en) 1982-12-31
EP0074229A1 (en) 1983-03-16
YU196382A (en) 1985-03-20
PH17423A (en) 1984-08-08
HU188328B (en) 1986-04-28
FI822999A0 (fi) 1982-08-30
ATE19078T1 (de) 1986-04-15
CA1177485A (en) 1984-11-06
IE822087L (en) 1983-02-28
GR77241B (enExample) 1984-09-11
PL238095A1 (en) 1984-03-26
FI78085B (fi) 1989-02-28
AU534063B2 (en) 1984-01-05
PT75481A (en) 1982-09-01
AU8784182A (en) 1983-03-31
KR860000103B1 (ko) 1986-02-19
DE3270423D1 (en) 1986-05-15
AR230994A1 (es) 1984-08-31
DK386882A (da) 1983-04-07
EP0074229B1 (en) 1986-04-09
KR840001155A (ko) 1984-03-28
IE53586B1 (en) 1988-12-21
DK160303C (da) 1991-08-05
FI78085C (fi) 1989-06-12
YU42795B (en) 1988-12-31
PL134315B1 (en) 1985-08-31
DK160303B (da) 1991-02-25
FI822999L (fi) 1983-03-01

Similar Documents

Publication Publication Date Title
MY105494A (en) Triazole antifungal agents.
EP0196184A3 (en) New aryl derivatives
ES8105298A1 (es) Un procedimiento para la preparacion de imidazol-cianoguani-dinas.
ES2043830T3 (es) Un metodo para preparar un compuesto de bis-(metilenodioxi)bifenilo.
GB1418354A (en) Tricyclicicazaindole hypoglycemic agents
ES8308324A1 (es) Un procedimiento para la preparacion de un compuesto.
ES470746A1 (es) Un procedimiento para preparar derivados de dihidropirano 6-sustituido
ES8500935A1 (es) Un procedimiento para preparar derivados de piridina.
MY108849A (en) Novel compound
ES8801545A1 (es) Un procedimiento para la preparacion de compuestos aminoheterociclicos
GB1142309A (en) Improved urea derivatives and their use as herbicides
ES8607265A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes
PL226398A2 (enExample)
KR880002843A (ko) 3-퍼플루오로알킬-5-치환된-옥시-이속사졸 유도체, 그의 제조방법, 및 그를 함유하는 제초제
ES531933A0 (es) Un procedimiento para preparar un derivado de imidazolinona
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
PH24129A (en) New pyridine compounds with basic substituents,medicaments containing them and their use
GB1508022A (en) Triazine sulphenimides
GB8720414D0 (en) Chemical compounds
ES2042499T3 (es) Procedimiento para preparar un derivado de acido 2-piridilacetico.
EP0351979A3 (en) Azole derivatives of naphthaleone oxime esters
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
EP0301433A3 (en) Coating resin composition
PT84367A (en) Process for the preparation of a fungicidal compound containing a naphthimidezolone
PL255694A1 (en) Process for preparing novel derivatives of cyclopentylbutyn-2-one

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506